AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 272: E163-E172, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellerstein, M. K.
Right arrow Articles by Wu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellerstein, M. K.
Right arrow Articles by Wu, K.

AJP - Endocrinology and Metabolism, Vol 272, Issue 1 E163-E172, Copyright © 1997 by American Physiological Society


ARTICLES

Altered fluxes responsible for reduced hepatic glucose production and gluconeogenesis by exogenous glucose in rats

M. K. Hellerstein, R. A. Neese, J. M. Schwarz, S. Turner, D. Faix and K. Wu
Department of Nutritional Sciences, University of California, Berkeley 94720-3104, USA.

The net release of glucose from the liver, or hepatic glucose production (HGP), and apparent gluconeogenesis (GNG) are reduced by exogenous glucose. We investigated the changes in metabolic fluxes responsible. Flux through the hepatic GNG pathway was quantified by mass isotopomer distribution analysis (MIDA) from [2-13C]glycerol. Unidirectional flux across hepatic glucose-6-phosphatase (G-6-Pase), or total hepatic glucose output (THGO), and hepatic glucose cycling (HGC) were also measured by using glucuronate (GlcUA) to correct for glucose 6-phosphate (G-6-P) labeling. Infusion of glucose (15-30 mg.kg-1.min-1 iv) to 24 h-fasted rats caused two important metabolic alterations. First was a significant increase in hepatic glucose uptake and HGC: > 60% of THGO was from HGC. Second, although flux through hepatic G-6-P increased (from 15.7 to 17.7-22.7 mg.kg-1.min-1), the partitioning of G-6-P flux changed markedly [from 30-35% to 55-60% entering UDP-glucose (UDP-Glc), P < 0.01]. Total flux through the GNG pathway remained active during intravenous glucose, but increased partitioning into UDP-Glc lowered GNG flux plasma glucose by 50%. In summary, the suppression of HGP and GNG flux into glucose is not primarily due to reduced carbon flow through hepatic G-6-Pase or the hepatic GNG pathway. THGO persists, but hepatic G-6-P is derived increasingly from plasma glucose, and flow through GNG persists, but the partitioning coefficient of G-6-P into UDP-Glc doubles. These adjustments permit net HGP to fall despite increased total production of hepatic G-6-P during administration of glucose.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy
Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. Edgerton, S. Cardin, D. Neal, B. Farmer, M. Lautz, C. Pan, and A. D. Cherrington
Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E510 - E522.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. S. Edgerton, S. Cardin, C. Pan, D. Neal, B. Farmer, M. Converse, and A. D. Cherrington.
Effects of Insulin Deficiency or Excess on Hepatic Gluconeogenic Flux During Glycogenolytic Inhibition in the Conscious Dog
Diabetes, November 1, 2002; 51(11): 3151 - 3162.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. K. Trimmer, J.-M. Schwarz, G. A. Casazza, M. A. Horning, N. Rodriguez, and G. A. Brooks
Measurement of gluconeogenesis in exercising men by mass isotopomer distribution analysis
J Appl Physiol, July 1, 2002; 93(1): 233 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Jones, M. A. Solomon, S. M. Cole, A. D. Sherry, and C. R. Malloy
An integrated 2H and 13C NMR study of gluconeogenesis and TCA cycle flux in humans
Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E848 - E856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Noah, M. Krempf, G. Lecannu, P. Maugere, and M. Champ
Bioavailability of starch and postprandial changes in splanchnic glucose metabolism in pigs
Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E181 - E188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. F. Previs, G. W. Cline, and G. I. Shulman
A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo
Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E154 - E160.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Q. Siler, R. A. Neese, E. J. Parks, and M. K. Hellerstein
VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1] glycerol
J. Lipid Res., December 1, 1998; 39(12): 2319 - 2328.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Q. Siler, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein
The inhibition of gluconeogenesis following alcohol in humans
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E897 - E907.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. H. van Dijk, F. H. van der Sluijs, C. H. Wiegman, J. F. W. Baller, L. A. Gustafson, H.-J. Burger, A. W. Herling, F. Kuipers, A. J. Meijer, and D.-J. Reijngoud
Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted Rats. A PHARMACOLOGICAL STUDY WITH THE CHLOROGENIC ACID DERIVATIVE S4048
J. Biol. Chem., July 6, 2001; 276(28): 25727 - 25735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Chu, S. M. Sherck, K. Igawa, D. K. Sindelar, D. W. Neal, M. Emshwiller, and A. D. Cherrington
Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E402 - E411.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online